Cargando…

Treatment and chemoprevention of NSAID-associated gastrointestinal complications

The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Frech, Edward J, Go, Mae F
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697523/
https://www.ncbi.nlm.nih.gov/pubmed/19436617
_version_ 1782168334166392832
author Frech, Edward J
Go, Mae F
author_facet Frech, Edward J
Go, Mae F
author_sort Frech, Edward J
collection PubMed
description The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, including peptic ulcer disease and non-ulcer dyspepsia. A careful assessment of patients’ risk factors for developing NSAID-related gastrointestinal complications should be undertaken prior to initiation of any NSAIDs. Patients who are considered at risk for developing gastrointestinal complications should receive concurrent antisecretory medical therapy to minimize the risk for GI complications.
format Text
id pubmed-2697523
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26975232009-06-17 Treatment and chemoprevention of NSAID-associated gastrointestinal complications Frech, Edward J Go, Mae F Ther Clin Risk Manag Review The use of non-steroidal anti-inflammatory drugs has become ubiquitous worldwide and remains a common source of gastrointestinal morbidity. Antisecretory medications, particularly proton pump inhibitors, are effective in the treatment and prevention of NSAID-related gastrointestinal complications, including peptic ulcer disease and non-ulcer dyspepsia. A careful assessment of patients’ risk factors for developing NSAID-related gastrointestinal complications should be undertaken prior to initiation of any NSAIDs. Patients who are considered at risk for developing gastrointestinal complications should receive concurrent antisecretory medical therapy to minimize the risk for GI complications. Dove Medical Press 2009 2009-03-26 /pmc/articles/PMC2697523/ /pubmed/19436617 Text en © 2009 Frech and Go, publisher and licensee Dove Medical Press Ltd.
spellingShingle Review
Frech, Edward J
Go, Mae F
Treatment and chemoprevention of NSAID-associated gastrointestinal complications
title Treatment and chemoprevention of NSAID-associated gastrointestinal complications
title_full Treatment and chemoprevention of NSAID-associated gastrointestinal complications
title_fullStr Treatment and chemoprevention of NSAID-associated gastrointestinal complications
title_full_unstemmed Treatment and chemoprevention of NSAID-associated gastrointestinal complications
title_short Treatment and chemoprevention of NSAID-associated gastrointestinal complications
title_sort treatment and chemoprevention of nsaid-associated gastrointestinal complications
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697523/
https://www.ncbi.nlm.nih.gov/pubmed/19436617
work_keys_str_mv AT frechedwardj treatmentandchemopreventionofnsaidassociatedgastrointestinalcomplications
AT gomaef treatmentandchemopreventionofnsaidassociatedgastrointestinalcomplications